Latest News about GMAB
Recent news which mentions GMAB
Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways: Analyst
April 24, 2023
From Benzinga
3 Biotech Companies to Watch in 2023
January 06, 2023
From InvestorPlace
Our 7 Top Biotech Stock Picks for 2023
December 09, 2022
From InvestorPlace
3 Hot Stocks That Could Live Up to Their Lofty Valuations
December 08, 2022
From Motley Fool
Is AbbVie Stock a Buy Now?
December 06, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Monday
November 21, 2022
From Benzinga
3 Hail Mary Plays to Bring Your Stock Portfolio Back From the Brink
October 25, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
October 21, 2022
From Benzinga
Seagen, Zai Lab Ink Regional Strategic Licensing Agreement For Cervical Cancer Treatment
September 27, 2022
From Benzinga
HC Wainwright Is Bullish On This Multiple Myeloma Focused Stock
August 22, 2022
Tickers
GMAB
From Benzinga
Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases
August 05, 2022
From Benzinga
Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
August 05, 2022
From Benzinga
AbbVie To Submit European Application For Epcoritamab In Lymphoma Setting Later In 2022
July 18, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.